2025年1月7日 · Mevac-a is used for active immunization against disease caused by hepatitis A virus (HAV). Mevac-a is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV.

Mevac-A, is the only live-attenuated Hepatitis A vaccine that can provide a life-long protection with just one shot. No Booster dose needed.

Discover concise prescribing info for Mevac-A topical on MIMS including its uses, special precautions, interactions, dosages etc.

2024年2月29日 · กองยา สำนักงานคณะกรรมการอาหารและยา กระทรวงสาธารณสุข

Hepatitis A vaccine is recommended for pre-exposure prophylaxis of individuals at increased risk of infection and post-exposure prophylaxis. Thus the vaccine is indicated in the following conditions: 1. Residents of communities with high endemic rates or recurrent outbreaks of …

Worldwide, there are multiple formaldehyde-inactivated and at least two live attenuated hepatitis A vaccines now in clinical use. The impressive immunogenicity of inactivated vaccines is reflected in rapid seroconversion rates, enabling both preexposure and postexposure prophylaxis.

Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.

2024年3月1日 · 甲型肝炎病毒 (hav) 疫苗是预防自然 hav 感染的有效策略。 在泰国，有两种类型的甲型肝炎疫苗可供选择，包括灭活甲型肝炎疫苗和减毒活疫苗。 本研究旨在比较泰国 18 个月至...。临床试验注册。 ich gcp。

2020年9月27日 · Mevac-A Powder works by acting against the virus causing Hepatitis A. Detailed information related to Mevac-A Powder's uses, composition, dosage, side effects and reviews is listed below. Uses

- Hepatitis A is a serious liver disease caused by the Hepatitis A virus. - It is usually spread through close, personal contact with an infected person or by ingesting contaminated food or water. 2. Symptoms: